Home › Investors short Juno Therapeutics, Amgen stocks, but that may not be bad news
 

Keywords :   


Investors short Juno Therapeutics, Amgen stocks, but that may not be bad news

2015-03-03 04:12:21| Biotech - Topix.net

More investors were shorting their biotech stocks in the first half of February than in the previous month, according to financial news site Benzinga . Of the top three companies with the most short sells, two have Puget Sound ties: Seattle-based Juno Therapeutics and California-based Amgen , which has offices in Bothell and Seattle until the end of the year.

Tags: news short bad stocks

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Eastern North Pacific Tropical Weather Outlook
05.10Atlantic Tropical Weather Outlook
04.10Should you tip even if the service wasn't worth it?
04.10Hurricane Kirk Graphics
04.10Hurricane Kirk Forecast Discussion Number 22
04.10Tropical Storm Leslie Forecast Discussion Number 10
04.10Hurricane Kirk Wind Speed Probabilities Number 22
04.10Hurricane Kirk Public Advisory Number 22
More »